Eliquis Offered to Cash-Paying Patients at More Than 40% Discount to Current List Price, Sotyktu at More Than 80% Discount to Current List Price PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb ...
Bristol Myers Squibb (NYSE:BMY) announced an expansion of its direct-to-consumer offerings on Thursday, making its blood thinner Eliquis and psoriasis therapy Sotyktu available at sharply discounted ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback